FZD6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.66293670342566E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.89015511312618E-12 |
Normal-vs-Stage2 |
2.52420000002029E-06 |
Normal-vs-Stage3 |
1.4690000005313E-07 |
Normal-vs-Stage4 |
1.68810000422681E-08 |
Stage1-vs-Stage2 |
1.179760E-01 |
Stage1-vs-Stage3 |
5.080000E-01 |
Stage1-vs-Stage4 |
4.665600E-01 |
Stage2-vs-Stage3 |
5.225400E-01 |
Stage2-vs-Stage4 |
4.792800E-01 |
Stage3-vs-Stage4 |
9.793800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.68598468519576E-12 |
Normal-vs-AfricanAmerican |
5.07749953193581E-10 |
Normal-vs-Asian |
4.01429999999925E-05 |
Caucasian-vs-AfricanAmerican |
4.057400E-01 |
Caucasian-vs-Asian |
4.677600E-01 |
AfricanAmerican-vs-Asian |
9.134600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.16260359514808E-11 |
Normal-vs-Female |
4.08784117666983E-12 |
Male-vs-Female |
1.537400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.62909999995775E-06 |
Normal-vs-Age(41-60Yrs) |
4.7025050520233E-11 |
Normal-vs-Age(61-80Yrs) |
6.3813998529838E-10 |
Normal-vs-Age(81-100Yrs) |
1.10679999998364E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.032400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.618400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.267600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.729600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.916180E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.815200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.568000E-04 |
Normal-vs-Grade 2 |
6.94059998362917E-09 |
Normal-vs-Grade 3 |
2.87991852587766E-13 |
Normal-vs-Grade 4 |
2.82430000053679E-07 |
Grade 1-vs-Grade 2 |
3.725000E-01 |
Grade 1-vs-Grade 3 |
2.469900E-02 |
Grade 1-vs-Grade 4 |
4.317000E-01 |
Grade 2-vs-Grade 3 |
2.373800E-02 |
Grade 2-vs-Grade 4 |
9.895200E-01 |
Grade 3-vs-Grade 4 |
1.189970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.90392146492968E-12 |
Normal-vs-ccB subtype |
3.57100000003552E-06 |
ccA subtype-vs-ccB subtype |
6.197100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.21930002048043E-09 |
Normal-vs-N1 |
8.782700E-03 |
N0-vs-N1 |
6.018200E-01 |
|
|